A Premier Boutique
Investment Bank
Specializing in PIPEs, Reverse Mergers,
M&A, Private Equity & LP Equity for CRE
  • HMNY AYRO
  • HMNY AYRO
  • HMNY MoviePass
  • Phase Rx
  • PallAdium Capital Advisor
  • PallAdium Capital Advisor

Palladium Capital Advisors, Financial Advisor on $30 million Public Offering for Helios & Matheson Analytics (NASDAQ:HMNY)

Apr. 19, 2018:

NEW YORK–(April 19, 2018)–Palladium Capital Advisors, LLC acted as financial advisor to Helios and Matheson Analytics Inc. (Nasdaq: HMNY) (“HMNY”), a provider of information technology services and solutions and the 92% owner of MoviePass Inc. (“MoviePass”), the nation’s premier movie-theater subscription service, who today announced the pricing of a best efforts underwritten public offering of an aggregate of 10,500,000 Series A-2 units (the “Series A-2 Units”), with each Series A-2 Unit consisting of (i) one share of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and (ii) one Series A-2 Warrant to purchase one share of Common Stock (the “Series A-2 Warrants”); and 500,000 Series B-2 units (the “Series B-2 Units”, and together with the Series A-2 Units, the “Units”), with each Series B-2 Unit consisting of (i) one pre-funded Series B-2 Warrant to purchase one share of Common Stock (the “Series B-2 Warrants”, and together with the Series A-2 Warrants, the “Warrants”) and (ii) one Series A-2 Warrant, with anticipated gross proceeds of approximately $30 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by HMNY. HMNY is offering the Units at a price of $2.75 per Unit. All of the Units are being offered by HMNY. The shares of common stock and warrants will be issued separately. The Warrants will be exercisable at any time on or after the issuance date until the five-year anniversary of the issuance date. Each Series A-2 Warrant will be exercisable at a price of $3.00 per share of common stock. Each Series B-2 Warrant will have an aggregate exercise price of $2.75 per share of common stock, all of which will be pre-funded except for a nominal exercise price of $0.001 per share of common stock. There is no established public trading market for the Warrants and HMNY does not expect a market to develop in the future. The offering is expected to close on or about April 23, 2018, subject to customary closing conditions. HMNY may use the net proceeds from this offering to increase the Company’s ownership stake in MoviePass or to support the operations of MoviePass and MoviePass Ventures; to satisfy a portion or all of any amounts payable in connection with previously issued convertible notes; and for general corporate purposes and transaction expenses. The Company may also use the proceeds to make other acquisitions.

Canaccord Genuity is acting as sole book-running manager for the offering, with Roth Capital Partners and Maxim Group acting as co-managers. Palladium Capital Advisors, LLC acted as a financial advisor in connection with the offering.

The Units, the Shares, the Warrants and the shares of Common Stock underlying the Warrants described above are being offered pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (“SEC”). A preliminary prospectus supplement and accompanying prospectus relating to the offering has been filed with the SEC and is available for free on the SEC’s website at www.sec.gov. Copies of the final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s web site at www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may also be obtained, when available, from Canaccord Genuity LLC, Attention: Equity Syndicate Department, 99 High Street, 12th Floor, Boston, Massachusetts 02110, by telephone at (617) 371-3900, or by email at prospectus@canaccordgenuity.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

About Helios and Matheson Analytics Inc.

Helios and Matheson Analytics Inc. (HMNY) is a provider of information technology services and solutions, offering a range of technology platforms focusing on big data, artificial intelligence, business intelligence, social listening, and consumer-centric technology. HMNY owns approximately 92% of the outstanding shares (excluding options and warrants) of MoviePass Inc., the nation’s premier movie-theater subscription service. HMNY’s holdings include RedZone Map™, a safety and navigation app for iOS and Android users, and a community-based ecosystem that features a socially empowered safety map app that enhances mobile GPS navigation using advanced proprietary technology. HMNY is headquartered in New York, NY and listed on the Nasdaq Capital Market under the symbol HMNY. For more information, visit us at www.hmny.com.

About MoviePass

MoviePass Inc. is a technology company dedicated to enhancing the exploration of cinema. As the nation’s premier movie-theater subscription service, MoviePass provides film enthusiasts the ability to attend up to one movie per day for a low subscription price. The service, now accepted at more than 91% of theaters across the United States, is the nation’s largest theater network. For more information, visit www.moviepass.com.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including but not limited to statements regarding HMNY’s expectations on the completion, timing and size of the proposed public offering and the anticipated use of proceeds therefrom. These forward-looking statements are subject to a number of risks, including market conditions related to the proposed public offering and the risk factors set forth from time to time in HMNY’s SEC filings, including but not limited to the risks that are described in the “Risk Factors” section of HMNY’s Annual Report on Form 10-K for the year ended December 31, 2017, and in the preliminary prospectus supplement related to the proposed offering filed with the SEC on April 18, 2018, each available on the SEC’s web site at www.sec.gov. In addition to the risks described above and in HMNY’s other filings with the SEC, other unknown or unpredictable factors also could affect HMNY’s results. No forward-looking statements can be guaranteed, and actual results (including, without limitation, the ability to complete this offering and generate the net proceeds necessary for HMNY to complete its business objectives) could differ significantly from those contemplated by the forward-looking statements. The information in this release is provided only as of the date of this release, and HMNY undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.